Eli Lilly's $3.25 billion acquisition of Kelonia Therapeutics caps startup's tortuous ride statnews.comLilly to buy Boston biotech Kelonia for $3.25 billion in latest Mass. investment The Boston GlobeEli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion CNBCWhy Legend Biotech Stock Crushed the Market on Monday The Motley Fool
